These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 8593013)
1. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid. Child J; Mortiboy D; Andrews JM; Chow AT; Wise R Antimicrob Agents Chemother; 1995 Dec; 39(12):2749-51. PubMed ID: 8593013 [TBL] [Abstract][Full Text] [Related]
2. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers. Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057 [TBL] [Abstract][Full Text] [Related]
4. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose. Wise R; Andrews JM; Ashby JP; Marshall J J Antimicrob Chemother; 1999 Nov; 44(5):701-4. PubMed ID: 10552990 [TBL] [Abstract][Full Text] [Related]
5. The clinical pharmacokinetics of levofloxacin. Fish DN; Chow AT Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926 [TBL] [Abstract][Full Text] [Related]
6. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Gotfried MH; Danziger LH; Rodvold KA Chest; 2001 Apr; 119(4):1114-22. PubMed ID: 11296178 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients. Piscitelli SC; Spooner K; Baird B; Chow AT; Fowler CL; Williams RR; Natarajan J; Masur H; Walker RE Antimicrob Agents Chemother; 1999 Sep; 43(9):2323-7. PubMed ID: 10471591 [TBL] [Abstract][Full Text] [Related]
8. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin. Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine. Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219). Wise R; Mortiboy D; Child J; Andrews JM Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of levofloxacin in healthy Thai male volunteers. Chulavatnatol S; Chindavijak B; Vibhagool A; Wananukul W; Sriapha C; Sirisangtragul C J Med Assoc Thai; 1999 Nov; 82(11):1127-35. PubMed ID: 10659548 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit. Rebuck JA; Fish DN; Abraham E Pharmacotherapy; 2002 Oct; 22(10):1216-25. PubMed ID: 12389872 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin. Johnson JH; Cooper MA; Andrews JM; Wise R Antimicrob Agents Chemother; 1992 Nov; 36(11):2444-6. PubMed ID: 1336947 [TBL] [Abstract][Full Text] [Related]
14. Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate. Wise R; Gee T; Marshall G; Andrews JM Antimicrob Agents Chemother; 2002 Jan; 46(1):242-4. PubMed ID: 11751144 [TBL] [Abstract][Full Text] [Related]
15. Penetration of levofloxacin into skin tissue after oral administration of multiple 750 mg once-daily doses. Chow AT; Chen A; Lattime H; Morgan N; Wong F; Fowler C; Williams RR J Clin Pharm Ther; 2002 Apr; 27(2):143-50. PubMed ID: 11975700 [TBL] [Abstract][Full Text] [Related]
16. Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. Rodvold KA; Danziger LH; Gotfried MH Antimicrob Agents Chemother; 2003 Aug; 47(8):2450-7. PubMed ID: 12878504 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue penetration of orally administered lomefloxacin. Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181 [TBL] [Abstract][Full Text] [Related]